Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer

Open access
Xu, Jun, Hu, Shengnan, Chen, Qiuli, Shu, Lilu, Wang, Peter, Wang, Jianjiang · 2023 · Scientific Reports

Abstract

In recent years, molecular and genetic research hotspots of gastric cancer have been investigated, including microRNAs, long noncoding RNAs (lncRNAs) and messenger RNA (mRNAs). The study on the role of lncRNAs may help to develop personalized treatment and identify potential prognostic biomarkers in gastric cancer. The RNA-seq and miRNA-seq data of gastric cancer were downloaded from the TCGA database. Differential analysis of RNA expression between gastric cancer samples and normal samples was performed using the edgeR package. The ceRNA regulatory network was visualized using Cytoscape. KEGG pathway analysis of mRNAs in the ceRNA network was performed using the clusterProfiler package. CIBERSORT was used to distinguish 22 immune cell types and the prognosis-related genes and immune cells were determined using Kaplan-Meier and Cox proportional hazard analyses. To estimate these nomograms, we used receiver operating characteristic and calibration curve studies. The ceRNA regulation network of gastric cancer was built in this study, and the genes in the network were analyzed for prognosis. A total of 980 lncRNAs were differentially expressed, of which 774 were upregulated and 206 were downregulated. A survival study identified 15 genes associated with gastric cancer prognosis, including VCAN-AS1, SERPINE1, AL139002.1, LINC00326, AC018781.1, C15orf54, hsa-miR-145. Monocytes and Neutrophils were associated with the survival rate of gastric cancer. Our research uncovers new ceRNA network for the detection, treatment, and monitoring of gastric cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-023-41444-3

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Volcano plots and heatmaps of differentially expressed mRNAs, miRNAs, and lncRNAs. (A) Volcano plot of differentially expressed mRNAs, miRNAs and lncRNAs. (B) Heatmap of differentially expressed mRNAs, miRNAs and lncRNAs. (C) LncRNA-miRNA-mRNA ceRNA network generated by Cytoscape. Red: upregulated RNAs. Green: downregulated RNAs. Triangle: miRNA. Diamond: lncRNA. Circular: mRNA.
Figure 1 Volcano plots and heatmaps of differentially expressed mRNAs, miRNAs, and lncRNAs. (A) Volcano plot of differentially expressed mRNAs, miRNAs and lncRNAs. (B) Heatmap of differentially expressed mRNAs, miRNAs and lncRNAs. (C) LncRNA-miRNA-mRNA ceRNA network generated by Cytoscape. Red: upregulated RNAs. Green: downregulated RNAs. Triangle: miRNA. Diamond: lncRNA. Circular: mRNA.CC BY · PubMed Central
Figure 2 Prognosis-related genes were illustrated by the K-M survival evaluation.
Figure 2 Prognosis-related genes were illustrated by the K-M survival evaluation.CC BY · PubMed Central
Figure 3 LASSO and multivariate regression models screening genes. (A) LASSO coefficient profiles of genes in STAD; dotted vertical lines were drawn at the optimal values by using the minimum criteria. (B) LASSO coefficient profiles of the candidate OS-related GRGs with nonzero coefficients determined by the optimal lambda. A coefficient profile plot was produced against the logλ sequence. (C) Forest plot of several genes was involved in the ceRNA network. (D) Risk score analyses of GC patients in the training cohort based on the seven-GRGs signature. Distribution of risk scores per patient. (E) Relationships between survival status and survival times of GC patients ranked by risk score. The black dotted line represents the optimum cut-off point dividing patients into low and high-risk groups.
Figure 3 LASSO and multivariate regression models screening genes. (A) LASSO coefficient profiles of genes in STAD; dotted vertical lines were drawn at the optimal values by using the minimum criteria. (B) LASSO coefficient profiles of the candidate OS-related GRGs with nonzero coefficients determined by the optimal lambda. A coefficient profile plot was produced against the logλ sequence. (C) Forest plot of several genes was involved in the ceRNA network. (D) Risk score analyses of GC patients in the training cohort based on the seven-GRGs signature. Distribution of risk scores per patient. (E) Relationships between survival status and survival times of GC patients ranked by risk score. The black dotted line represents the optimum cut-off point dividing patients into low and high-risk groups.CC BY · PubMed Central
Figure 4 The association of ceRNAs and survival. (A) KM analysis of the high-risk and low-risk groups. (B) Time-dependent receiver operating characteristic (ROC) analysis for OS prediction of prediction model. (C) Heatmap of seven differentially expressed genes. (D) Nomogram based on multiple Cox regression. (E) Calibration curve for 3 years survival.
Figure 4 The association of ceRNAs and survival. (A) KM analysis of the high-risk and low-risk groups. (B) Time-dependent receiver operating characteristic (ROC) analysis for OS prediction of prediction model. (C) Heatmap of seven differentially expressed genes. (D) Nomogram based on multiple Cox regression. (E) Calibration curve for 3 years survival.CC BY · PubMed Central
Figure 5 The association of immune cells and STAD. (A) The percentage of 22 immune cell subpopulations in STAD patients. (B) The fraction of immune cells in STAD patients. (C) Heatmap of immune infiltration between normal and tumor groups.
Figure 5 The association of immune cells and STAD. (A) The percentage of 22 immune cell subpopulations in STAD patients. (B) The fraction of immune cells in STAD patients. (C) Heatmap of immune infiltration between normal and tumor groups.CC BY · PubMed Central
Figure 6 The correlation of immune cells and STAD. (A) T cells CD4 memory activated and survival in STAD. (B) Co-expression patterns among fractions of immune cells.
Figure 6 The correlation of immune cells and STAD. (A) T cells CD4 memory activated and survival in STAD. (B) Co-expression patterns among fractions of immune cells.CC BY · PubMed Central
Figure 7 Correlation between immune cells and clinical features.
Figure 7 Correlation between immune cells and clinical features.CC BY · PubMed Central
Figure 8 The association of immune cells and survival in STAD. (A) Survival probability of high and low-risk groups (left). AUC curve at 1, 3, 5 years (right). (B) Nomogram for predicting patients’ outcome based on immune cells (left). Calibration curves for assessing the discrimination and accuracy of the nomogram (right). (C–D) The association between immune cells and prognostic genes.
Figure 8 The association of immune cells and survival in STAD. (A) Survival probability of high and low-risk groups (left). AUC curve at 1, 3, 5 years (right). (B) Nomogram for predicting patients’ outcome based on immune cells (left). Calibration curves for assessing the discrimination and accuracy of the nomogram (right). (C–D) The association between immune cells and prognostic genes.CC BY · PubMed Central
Figure 9 The association of immune cells and survival in STAD. (A) Heatmap of the immune cells (monocytes and neutrophils) in high-risk and low-risk groups. (B) correlation matrix of immune cells and genes.
Figure 9 The association of immune cells and survival in STAD. (A) Heatmap of the immune cells (monocytes and neutrophils) in high-risk and low-risk groups. (B) correlation matrix of immune cells and genes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 87 references

Cited by

See all 6

Metadata

Authors
Xu, J., Hu, S., Chen, Q., Shu, L., Wang, P., & Wang, J.
Affiliations
Hangzhou Medical College (CN)
Corresponding author
  • Wang, Peter
  • Wang, Jianjiang
Venue
Scientific Reports
Published
2023-09-11
Volume
13
Issue
1
Pages
15006-15006
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4386614956
Cited by
6
References
87
Citations by year
2026: 1 · 2025: 4 · 2024: 1
FWCI
0.76
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords
gastric cancer, long non-coding RNA, ceRNA regulatory network, tumor immune microenvironment, prognostic factors, differentially expressed lncRNAs, immune cell infiltration, monocytes, neutrophils, survival analysis
MeSH terms
Humans, RNA, Messenger, Stomach Neoplasms, Computational Biology, RNA, Untranslated, MicroRNAs, Tumor Microenvironment, RNA, Long Noncoding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer. https://app.cochat.ai/papers/10.1038/s41598-023-41444-3
The paper
Xu, J., Hu, S., Chen, Q., Shu, L., Wang, P., & Wang, J. (2023). Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer. Scientific Reports. https://doi.org/10.1038/s41598-023-41444-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.